Alterations in gut glutamate metabolism associated with changes in gut microbiota composition in children with autism spectrum disorder

mSystems

Volumn 4, Issue 1, 2019, Pages

  Wang, Mingbang ^a   Wan, Jing ^b   Rong, Han ^c   He, Fusheng ^d   Wang, Hui ^a   Zhou, Jiaxiu ^e   Cai, Chunquan ^f   Wang, Yan ^d   Xu, Ruihuan ^g   Yin, Zhaoqing ^b   Zhou, Wenhao ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b People s Hospital of Dehong Autonomous Prefecture   (China)

^c SHENZHEN KANGNING HOSPITAL   (China)

^d Imunobio   (China)

^e SHENZHEN CHILDREN'S HOSPITAL   (China)

^f Institute of Neurology   (China)

^g Longgang Central Hospital   (China)

Author keywords

Autism; Glutamate; Gut microbiota; Liquid chromatography mass spectrometry; Metabolome; Metagenome

Indexed keywords

ALANINE; ASPARTIC ACID; BIOLOGICAL MARKER; CHENODEOXYCHOLIC ACID; GLUTAMIC ACID; HYDROCORTISONE; TAUROCHOLIC ACID;

ACTINOBACTERIA; AMINO ACID METABOLISM; ARTICLE; AUTISM; BACTEROIDES VULGATUS; BETAPROTEOBACTERIA; BIOINFORMATICS; CAMPYLOBACTER JEJUNI; CHILD; CHLORACIDOBACTERIUM THERMOPHILUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM CELLULOLYTICUM; CONTROLLED STUDY; EGGERTHELLA LENTA; FECES ANALYSIS; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; METAGENOME; METAGENOMICS; PRINCIPAL COMPONENT ANALYSIS; PROTEUS MIRABILIS; SPECIES RICHNESS; SPIROCHAETA; SPIROCHAETA THERMOPHILA;

EID: 85066168381     PISSN: None     EISSN: 23795077     Source Type: Journal    
DOI: 10.1128/MSYSTEMS.00321-18     Document Type: Article

References (31)

1. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. 2015. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl Health Stat Report 13:1–20.
2. Muhle RA, Reed HE, Stratigos KA, Veenstra-VanderWeele J. 2018. The emerging clinical neuroscience of autism spectrum disorder: a review. JAMA Psychiatry 75:514–523. https://doi.org/10.1001/jamapsychiatry.2017.4685.
3. Vuong HE, Hsiao EY. 2017. Emerging roles for the gut microbiome in autism spectrum disorder. Biol Psychiatry 81:411–423. https://doi.org/10.1016/j.biopsych.2016.08.024.
4. Kang DW, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, Pollard EL, Roux S, Sadowsky MJ, Lipson KS, Sullivan MB, Caporaso JG, Krajmalnik-Brown R. 2017. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5:10. https://doi.org/10.1186/s40168-016-0225-7.
5. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:1451–1463. https://doi.org/10.1016/j.cell.2013.11.024.
6. Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyas B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S. 2014. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6:263ra158. https://doi.org/10.1126/scitranslmed.3009759.
7. Nelson SB, Valakh V. 2015. Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron 87:684–698. https://doi.org/10.1016/j.neuron.2015.07.033.
8. Gogolla N, Leblanc JJ, Quast KB, Sudhof TC, Fagiolini M, Hensch TK. 2009. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 1:172–181. https://doi.org/10.1007/s11689 -009-9023-x.
9. Tebartz van Elst L, Maier S, Fangmeier T, Endres D, Mueller GT, Nickel K, Ebert D, Lange T, Hennig J, Biscaldi M, Riedel A, Perlov E. 2014. Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis. Mol Psychiatry 19:1314 –1325. https://doi.org/10.1038/mp.2014.62.
10. Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, Shi J, Zhao S, Liu W, Wang X, Xia H, Liu Z, Cui B, Liang P, Xi L, Jin J, Ying X, Wang X, Zhao X, Li W, Jia H, Lan Z, Li F, Wang R, Sun Y, Yang M, Shen Y, Jie Z, Li J, Chen X, Zhong H, Xie H, Zhang Y, Gu W, Deng X, Shen B, Xu X, Yang H, Xu G, Bi Y, Lai S, Wang J, Qi L, Madsen L, Wang J, Ning G, Kristiansen K, Wang W. 2017. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med 23:859 – 868. https://doi.org/10.1038/nm.4358.
11. Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. 2018. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell 173:1728–1741.e1713. https://doi.org/10.1016/j.cell.2018.04.027.
12. van der Stel AX, van Mourik A, Laniewski P, van Putten JP, Jagusztyn-Krynicka EK, Wosten MM. 2015. The Campylobacter jejuni RacRS two-component system activates the glutamate synthesis by directly up-regulating gamma-glutamyltranspeptidase (GGT). Front Microbiol 6:567. https://doi.org/10.3389/fmicb.2015.00567.
13. Curin JM, Terzic J, Petkovic ZB, Zekan L, Terzic IM, Susnjara IM. 2003. Lower cortisol and higher ACTH levels in individuals with autism. J Autism Dev Disord 33:443–448.
14. Taylor JL, Corbett BA. 2014. A review of rhythm and responsiveness of cortisol in individuals with autism spectrum disorders. Psychoneuroendocrinology 49:207–228. https://doi.org/10.1016/j.psyneuen .2014.07.015.
15. Spratt EG, Nicholas JS, Brady KT, Carpenter LA, Hatcher CR, Meekins KA, Furlanetto RW, Charles JM. 2012. Enhanced cortisol response to stress in children in autism. J Autism Dev Disord 42:75–81. https://doi.org/10.1007/s10803-011-1214-0.
16. Huo R, Zeng B, Zeng L, Cheng K, Li B, Luo Y, Wang H, Zhou C, Fang L, Li W, Niu R, Wei H, Xie P. 2017. Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis. Front Cell Infect Microbiol 7:489. https://doi.org/10.3389/fcimb.2017.00489.
17. Dennis RL. 2016. Adrenergic and noradrenergic regulation of poultry behavior and production. Domest Anim Endocrinol 56(Suppl):S94–S100. https://doi.org/10.1016/j.domaniend.2016.02.007.
18. Toth M, Ziegler M, Sun P, Gresack J, Risbrough V. 2013. Impaired conditioned fear response and startle reactivity in epinephrine-deficient mice. Behav Pharmacol 24:1–9. https://doi.org/10.1097/FBP.0b013e32835cf408.
19. Mattila ML, Hurtig T, Haapsamo H, Jussila K, Kuusikko-Gauffin S, Kielinen M, Linna SL, Ebeling H, Bloigu R, Joskitt L, Pauls DL, Moilanen I. 2010. Comorbid psychiatric disorders associated with Asperger syndrome/ high-functioning autism: a community- and clinic-based study. J Autism Dev Disord 40:1080–1093. https://doi.org/10.1007/s10803-010-0958-2.
20. Heberling CA, Dhurjati PS, Sasser M. 2013. Hypothesis for a systems connectivity model of autism spectrum disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability. Med Hypotheses 80:264–270. https://doi.org/10.1016/j.mehy.2012.11.044.
21. Vogt T. 2010. Phenylpropanoid biosynthesis. Mol Plant 3:2–20. https://doi.org/10.1093/mp/ssp106.
22. Tanaka Y, Matsuoka M, Yamanoto N, Ohashi Y, Kano-Murakami Y, Ozeki Y. 1989. Structure and characterization of a cDNA clone for phenylalanine ammonia-lyase from cut-injured roots of sweet potato. Plant Physiol 90:1403–1407. https://doi.org/10.1104/pp.90.4.1403.
23. Zhou J, He F, Yang F, Yang Z, Xie Y, Zhou S, Liang J, Xu R, Wang Y, Guo H, Zhou W, Wang M. 2017. Increased stool immunoglobulin A level in children with autism spectrum disorders. Res Dev Disabil 82:90–94. https://doi.org/10.1016/j.ridd.2017.10.009.
24. Wang M, Zhou J, He F, Cai C, Wang H, Wang Y, Lin Y, Rong H, Cheng G, Xu R, Zhou W. 2019. Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders. Brain Behav Immun 75: 192–199. https://doi.org/10.1016/j.bbi.2018.10.006.
25. Drossman DA. 2016. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 150: 1262–1279.e2. https://doi.org/10.1053/j.gastro.2016.02.032.
26. Zhou S, Xu R, He F, Zhou J, Wang Y, Zhou J, Wang M, Zhou W. 2016. Diversity of gut microbiota metabolic pathways in 10 pairs of Chinese infant twins. PLoS One 11:e0161627. https://doi.org/10.1371/journal.pone.0161627.
27. Zhou S, Wang Z, He F, Qiu H, Wang Y, Wang H, Zhou J, Zhou J, Cheng G, Zhou W, Xu R, Wang M. 2019. Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis. J Nutr Biochem 63:54–61. https://doi.org/10.1016/j.jnutbio.2018.09.016.
28. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60. https://doi.org/10.1038/nature11450.
29. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https://doi.org/10.1186/s13059-014-0550-8.
30. Xue J, Balamurugan S, Li DW, Liu YH, Zeng H, Wang L, Yang WD, Liu JS, Li HY. 2017. Glucose-6-phosphate dehydrogenase as a target for highly efficient fatty acid biosynthesis in microalgae by enhancing NADPH supply. Metab Eng 41:212–221. https://doi.org/10.1016/j.ymben.2017.04 .008.
31. Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J. 2018. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46:W486 –W494. https://doi.org/10.1093/nar/gky310.